Locanabio

About:

Locana develops RNA-targeting gene therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

Website: https://www.locanabio.com/

Twitter/X: locanabio

Top Investors: Temasek Holdings, Google Ventures, ARCH Venture Partners, Muscular Dystrophy Association, Invus

Description:

Locanabio, Inc., is an RNA-targeting gene therapy company focused on developing therapies for patients with severe neurodegenerative, neuromuscular, and retinal diseases.

Total Funding Amount:

$156M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)locanabio.com

Founders:

David Nelles, Gene Yeo

Number of Employees:

101-250

Last Funding Date:

2020-12-14

IPO Status:

Private

Industries: